Losses narrow at Cymra Life Sciences as CEO bemoans ‘unfair trading conditions’ by Steve Jones November 13, 2024November 14, 2024 Byron Bay-based Cymra Life Sciences halved its losses in FY24 as sales rocketed to more than […]
Cannabis inquiry ‘will convince’ state premiers that reform is long overdue by Steve Jones August 22, 2024August 22, 2024
Releaf Group and Botanic Wellness among six firms hit with TGA fines by Steve Jones June 26, 2024June 27, 2024
Cymra Life Sciences reports positive results from pain trial, looks to double production capacity by Martin Lane July 11, 2023April 30, 2024
It’s time for the TGA to give Australian cannabis companies a fair go by Martin Lane February 10, 2021April 26, 2024
Australia’s cannabis industry has huge global potential, but we must innovate to maximise it by Martin Lane January 12, 2021April 29, 2024
Exclusive: Department of Health considers making imported medical cannabis meet GMP standards by Rhys Cohen October 6, 2020April 26, 2024
